Literature DB >> 1915388

Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges.

C A Gogos1, T G Maraziotis, N Papadakis, D Beermann, D K Siamplis, H P Bassaris.   

Abstract

The penetration of ciprofloxacin into the cerebrospinal fluid (CSF) in 25 patients with non-inflamed meninges and in 9 patients with inflamed meninges was studied. In the patients with non-inflamed meninges plasma and CSF were obtained 1-10 h after the second dose of ciprofloxacin and in the patients with inflamed meninges 1, 2, 3, 5, 7 and 9 h after the second dose. In the first group (non-inflamed meninges) data from 6 patients were obtained 4, 5 and 6 h post-dose. Mean ciprofloxacin concentrations in the CSF ranged from 0.073 mg/l to 0.106 mg/l during this observation time, while in the second group (inflamed meninges) they ranged from 0.089 to 0.260 mg/l. These results demonstrate that ciprofloxacin diffuses into the CSF at concentrations which exceed the MICs of Neisseria meningitidis and most gram-negative aerobic bacilli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915388     DOI: 10.1007/bf01963940

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  [Gyrase inhibitors: unwanted central nervous system effects].

Authors:  N Rietbrock; A H Staib
Journal:  Dtsch Med Wochenschr       Date:  1987-01-30       Impact factor: 0.628

2.  Study of the cerebrospinal fluid penetrability of ofloxacin.

Authors:  G Stübner; W Weinrich; U Brands
Journal:  Infection       Date:  1986       Impact factor: 3.553

3.  Penetration of ciprofloxacin into cerebrospinal fluid.

Authors:  G Valainis; D Thomas; G Pankey
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

4.  Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis.

Authors:  M Wolff; L Boutron; E Singlas; B Clair; J M Decazes; B Regnier
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  Gram-negative bacillary meningitis.

Authors:  J L LeFrock; B R Smith; A Molavi
Journal:  Med Clin North Am       Date:  1985-03       Impact factor: 5.456

6.  Ciprofloxacin for Pseudomonas aeruginosa meningitis.

Authors:  M R Millar; M A Bransby-Zachary; D S Tompkins; P M Hawkey; R Myles Gibson
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321

7.  The in vitro and in vivo activity of ciprofloxacin.

Authors:  H J Zeiler; K Grohe
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

8.  Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis.

Authors:  J P Stahl; J Croize; M A Lefèbvre; J P Bru; A Guyot; D Leduc; J B Fourtillan; M Micoud
Journal:  Infection       Date:  1986       Impact factor: 3.553

9.  Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.

Authors:  M Wolff; B Regnier; C Daldoss; M Nkam; F Vachon
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

10.  Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.

Authors:  J Dow; J Chazal; A M Frydman; P Janny; R Woehrle; F Djebbar; J Gaillot
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

  10 in total
  3 in total

1.  Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin.

Authors:  Adam L Vanwert; Chutima Srimaroeng; Douglas H Sweet
Journal:  Mol Pharmacol       Date:  2008-04-01       Impact factor: 4.436

Review 2.  Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?

Authors:  Nilesh Kumta; Jason A Roberts; Jeffrey Lipman; Menino Osbert Cotta
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

3.  Successful Use of Ertapenem for the Treatment of Enterobacter cloacae Complex Infection of the Central Nervous System (CNS).

Authors:  Sunish Shah; Dayna McManus; Jeffrey E Topal
Journal:  Case Rep Infect Dis       Date:  2019-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.